New funding
WaveTec VisionR, which recently introduced the ORA System™, a diagnostic device that brings revolutionary precision to cataract surgery, has recently closed a new round of financing, securing an additional $16.5m. This latest round was led by a new investor, Burrill & Company. All of the company’s previous investors also participated in this round of financing, including Versant Ventures, Accuitive Medical Ventures, De Novo Ventures and Gund Investment Corporation “The participation of a new lead investor further validates the scientific and clinical potential of the ORA System,†said Tom Frinzi, WaveTec president and CEO. “This new capital enables us to further expand our commercial efforts as well as continue product refinement,†he said.
Latest Articles
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.
AI Scribing and Telephone Management
Automating note-taking and call centres could boost practice efficiency.
AI Analysis and the Cornea
A combination of better imaging and AI deep learning could significantly improve corneal imaging and diagnosis.
Cooking a Feast for the Eyes
A cookbook to promote ocular health through thoughtful and traditional cuisine.
Need to Know: Spherical Aberration
Part three of this series examines spherical aberration and its influence on higher-order aberrations.
Generating AI’s Potential
How generative AI impacts medicine, society, and the environment.